Tag: Pfizer

The Pfizer and AstraZeneca coronavirus vaccines are highly effective against the variant identified in India after two doses, a study has found.

A Spanish study on mixing Covid-19 vaccines has found that giving a dose of Pfizer’s drug to people who already received a first shot of AstraZeneca vaccine is highly safe and effective, preliminary results showed on Tuesday.

U.S. regulators authorized Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12 and said they could begin receiving shots as soon as Thursday.

Sri Lanka on Saturday approved Pfizer's COVID-19 vaccine for emergency use in Sri Lanka, as the island nation battles a third wave of the virus, while suffering a restricted supply of vaccines from neighboring India.

Pfizer Inc on Tuesday raised its forecast for 2021 COVID-19 vaccine sales by more than 70% to $26 billion and said demand from governments around the world fighting to halt the pandemic could contribute to its growth for years to come.

Global pharma major Pfizer is sending its medicines worth USD 70 million (over ₹ 510 crore), from its distribution centres in the US, Europe and Asia, that have been identified as part of India's COVID-19 treatment protocol, the company's Chairman and CEO Albert Bourla said on Monday.

Pfizer plans to provide its Covid-19 vaccine to India at a “not-for-profit” price, according to the company.

COVID-19 vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc reduced risk of infection by 80% two weeks or more after the first of two shots, according to data from a real-world U.S. study released on Monday.

Sri Lanka yesterday said talks to purchase coronavirus vaccines from Pfizer-biontech have been successful and a final agreement is expected to be reached soon. State Minister of Production, Supply and Regulation of Pharmaceuticals, Prof. Channa Jayasumana said that the US based company has offered to supply vaccines in special storage equipment during transportation.

Pfizer Inc has told the Indian government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance and freedom on pricing and exports, two sources with direct knowledge of the matter